FIELD: medicine.
SUBSTANCE: present invention relates to medicine, in particular to pharmacological compositions for treating proctologic diseases. Pharmacological composition contains 3.3-7.5 wt% methyluracil, 0.13-0.3 wt% of nifedipine, 0.13-0.3 wt% isosorbide dinitrate and 1.3-3 wt% lidocaine and pharmacologically acceptable carrier - balance. Preferably, composition consists of 5 wt% methyluracil, 0.2 wt% nifedipine, 0.2 wt% isosorbide dinitrate, 2 wt% lidocaine and pharmacologically acceptable carrier - balance. Pharmacological composition can be presented in form of gel, ointment, cream, suppositories, suspended gel, lotion, emulsion.
EFFECT: pharmacological composition according to invention ensures fast therapeutic effect.
4 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (EMBODIMENTS) | 2019 |
|
RU2733080C1 |
METHOD OF PREPARING A PHARMACEUTICAL GEL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (VERSIONS) | 2020 |
|
RU2730483C1 |
COMPOSITION FOR TREATING ANAL CRACKS BASED ON FELODIPINE | 2019 |
|
RU2710742C1 |
COMPOSITION FOR TREATING ANAL FISSURES | 2013 |
|
RU2538079C1 |
COMPOSITION FOR TREATING ANAL FISSURES IN FORM OF CREAM | 2015 |
|
RU2595799C1 |
COMPOSITION FOR PREVENTING OR TREATING PROCTOLOGICAL DISEASES | 2022 |
|
RU2814279C2 |
GEL INCLUDING NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE (VERSIONS), APPLICATION OF GEL INCLUDING NIFEDIPINE AND IDOCAINE HYDROCHLORIDE (VERSIONS), METHOD FOR PREPARATION OF GEL INCLUDING NIFEDIPINE AND IDOCAINE HYDROCHLORIDE, USING NANOTECHNOLOGY | 2015 |
|
RU2641570C2 |
TISOLUM-BASED PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ANAL FISSURES | 2012 |
|
RU2483721C1 |
SUPPOSITORY SHOWING ANTIINFLAMMATORY EFFECT | 1995 |
|
RU2097022C1 |
THERAPEUTICAL COMPOSITION FOR LOCAL TREATMENT OF HEMORRHOIDS, ANUS FISSURES, AND INFLAMMATORY DISEASES OF MUCOUS MEMBRANE OF RECTUM | 2004 |
|
RU2277926C2 |
Authors
Dates
2016-07-20—Published
2013-07-22—Filed